SUPPLEMENT TECHNOLOGY
The first truly personalized supplement platform protected by IP, driven by data, and designed to scale like software in a $55B legacy market. We're transforming how supplements are created, delivered, and experienced through cutting-edge technology and scientific precision.
THE PROBLEM
Overwhelming Choices
29,000+ products on the market with no clear guidance on what actually works for individual needs.
.png)
Low Absorption
Most pills deliver only 10% of their nutrients, wasting money and limiting effectiveness.
No Personalization
One-size-fits-all doesn't work for real bodies with unique needs and conditions.
We didn't set out to make another supplement. We built a better system that addresses these fundamental problems through technology, science, and innovation. The supplement industry has failed to evolve despite massive consumer demand for better solutions.
THE PERFECT MARKET MOMENT
Massive Established Market
$55B U.S. supplement industry with 25M Americans spending $100+/month on supplements that largely fail to deliver results.
Market Ready for Disruption
Shocking stagnation in delivery, absorption, and personalization creates an opportunity for innovation in a category that hasn't evolved.
Unique Timing
The convergence of AI capability, wearable adoption, and health data integration creates a perfect window for transformation.
We're upgrading a broken business category that already commands $55B in U.S. spend alone. This follows the same playbook as companies that transformed coffee, mattresses, razors, and eyeglasses. Investors have waited for a health tech company that could do what vitamins never could. Now, it exists.
THE OPPORTUNITY
$55B
US Market Size
Total supplement market value
16%
CAGR
Growth rate of personalized supplements
25M
High-Value Consumers
US adults spending $100+ monthly
340M
Annual Searches
Google searches related to supplements
This is a rare moment where a stable market meets inevitable transformation. The personalized supplement market is growing rapidly, reaching $4.5B and attracting consumers willing to invest in their health. With 10% of US adults spending over $100 monthly on supplements, there's a substantial high-value customer base ready for innovation.
MARKET VALIDATION & THE PERSONALIZATION GAP
Market Signals
-
Every major player attempting to appear personalized
-
Hundreds of millions invested in personalization claims
-
16% CAGR for pseudo-personalized vs. 6% for traditional
-
Consumers willing to pay premium prices
Technical Barriers
-
Algorithmic complexity beyond most companies
-
Delivery method limitations with traditional pills
-
Lack of integration with biomarker data
-
Inability to create customized formulations at scale
The rush to "look personalized" proves demand exists. Despite market demand, no competitor has delivered true personalization due to significant technical barriers. The first company to deliver actual personalization will capture the highest-value segments, with consumer disappointment with pseudo-personalized products creating ready conversion opportunity.
MARKET VALIDATION
The competitive landscape shows significant consumer interest in personalized supplements. Top competitors by monthly visitors include HUM Nutrition (370,606), Viome (269,584), Cuure (166,000), and Persona Nutrition (106,363).
Using a conservative 2% conversion rate, leading competitor Persona Nutrition generates approximately 2,127 new customers per month. This validates market demand and provides benchmarks for our customer acquisition strategy. Smaller competitors like Vous Vitamin (27,910), VitaRx (26,577), and VitaminLab (18,139) also demonstrate the breadth of interest in this category. And at the same time, none of them are truly personalizing the supplementation of their customers.
THE ILLUSION OF PERSONALIZATION
Competitor
Approach
Reality
Care/of, Persona
Static quiz → static pill pack
Pre-made products with personalized packaging
Rootine
DNA test → static formulation
Rarely changes, limited personalization
Viome
Gut microbiome test → standard supplements
Fancy labels on conventional products
Others
"AI" and "personalized" marketing
Marketing terms, not product delivery
What the market currently calls personalization is simply packaging and curation. Competitors aren't creating personalized formulas – they're matching you to pre-made products with no continuous adaptation to your changing body and limited ingredient combinations from pre-determined options.
The hard truth is that these aren't personalized systems. They're curated catalogs masquerading as personalized solutions while delivering the same old supplement experience with new marketing.
Our SOLUTION
90% Absorption
Superior liquid delivery
Real-Time Personalization
Formula evolves with your body
AI-Powered Evidence Engine
%20(1).png){kind=small}
%20(1).png){kind=small}
.png){kind=small}
Our hyper-personalized supplement platform is built on three pillars of innovation. Our AI-powered evidence engine analyzes 14 million peer-reviewed studies to include only ingredients with scientific backing, replacing marketing claims with scientific certainty. Real-time personalization integrates blood tests, wearables & health apps, with formulas evolving with your changing body - no static formulas or base packs.
Our liquid delivery method (US Patent #11,710,551) provides 90% bioavailability versus 10-20% for pills, essential for aging populations and those with GI issues.
TRUE PERSONALIZATION: THE ST DIFFERENCE
.png){kind=small}
Formula Creation From Scratchon
Each formula built entirely from scratch monthly based on evolving data - no two formulas are exactly alike
.png){kind=small}
Clinical-Grade Algorithmic Precision
PubMed-validated analysis with evidence-based inclusion criteria, medical condition-specific dosing, and risk-factor stratification
%20(1).png){kind=small}
Comprehensive Ingredient Approach
75+ active ingredients optimized across three delivery systems based on absorption kinetics and synergistic timing
.png){kind=small}
Continuous Evolution
True closed-loop system with monthly adjustments based on bloodwork changes, wearable data, and seasonal variations
Our approach creates 1.778×10^78 possible combinations – more than atoms in the observable universe. Each ingredient has a full clinical framework built from RCTs, Cochrane reviews, and NIH guidance, including inclusion/exclusion criteria, drug interactions, and optimal dosage forms.
COMPETITIVE ADVANTAGE
.png){kind=small}
Dynamic Data-Driven Personalization
While competitors rely on static quiz-based approaches, we build formulas from scratch monthly using real-time health data.
.png){kind=small}
Superior Delivery Method
Our liquid delivery achieves >90% absorption compared to just 10-20% for traditional pills.
.png){kind=small}
Evidence-Based Formulation
We replace marketing claims with PubMed-validated clinical research for every ingredient and interaction.
%20(1).png){kind=small}
Health Data Integration
Comprehensive integration of blood work and wearables creates a truly responsive system versus limited or no data integration from competitors.
What sets us apart from every competitor is our approach to true personalization. While others offer limited options, we provide 1.778×10^78 possible combinations with monthly algorithm-driven adjustments based on comprehensive health data.
PATENT PROTECTION: OUR COMPETITIVE MOAT
.png){kind=small}
Comprehensive IP Protection
Patent covers delivery method and personalization system
.png){kind=small}
Market Exclusivity
Protection through 2043
.png){kind=small}
Global Expansion Potential
PCT filings for international protection
U.S. Patent #11,710,551 (granted July 2023) secures our market position by protecting core aspects of our business: delivery of personalized supplement formulations, algorithm-driven personalization based on biomarkers, real-time adjustment of formulations, and multi-factorial personalization using our specific approach.
This forces competitors to use inferior delivery methods or different personalization approaches, creating a clear barrier to entry and enabling premium positioning without immediate price competition.
OUR TECHNOLOGY
Evidence-Based AI Engine
Our proprietary algorithm analyzes 14M peer-reviewed studies to create evidence-based inclusion criteria for all 75+ ingredients, with medical condition-specific dosing based on research.
Data Integration Platform
Seamlessly integrates blood tests, wearables & health apps to provide risk-factor stratification tailored to individual profiles and categorical adjustments based on age, weight, and medical history.
Optimized Delivery Systems
Three precisely formulated delivery methods (AM and PM Liquids, Daytime drink powder) with ingredients placed based on dosage capacity, absorption kinetics, and synergistic timing.
Our clinical-grade personalization technology delivers precision at scale, not guesswork. The system includes serum level calibration for optimal dosing, such as Vitamin D based on 25(OH)D level, weight, skin type, and UV exposure.
BUSINESS MODEL
.png){kind=small}
All-Inclusive Package
$149/month subscription includes personalized formula, bi-annual blood testing, health app integration, and ongoing updates.
.png){kind=small}
High-Value, High-Margin
Gross margins projected to rise from 45% to 65% over 5 years as automation and volume increase.
%20(1).png){kind=small}
Cost Savings
83% cost savings for customers versus buying ingredients separately, creating strong value proposition.
Our Personalized Health-as-a-Service (HaaS) model delivers exceptional value while maintaining strong unit economics. The subscription-based revenue model includes home delivery of personalized formulas that continuously adapt to changing health needs.
EBITDA growth is targeted at 35% as we scale operations and leverage technology for increased efficiency. This creates a sustainable business with strong profitability potential
A UNIQUE PERSPECTIVE
Born from Medical Necessity
As a Crohn's disease sufferer with six feet of intestines removed, Dr. Joshi was unable to absorb traditional supplements and faced supplement infusions. This personal challenge led him to apply his medical expertise to find a better solution.
The result is our innovative liquid delivery system that makes supplements 90% more effective than tablets by bypassing digestive limitations. This personal journey informs our mission to help others with absorption challenges.
Dr. Jatin Joshi brings both medical expertise and personal experience to Supplement Technology. As a former surgeon and Professor of Surgery specializing in evidence-based medicine, he understands the science behind effective supplementation.
Our company was founded to solve a real medical problem, not just to capitalize on a market opportunity. This authentic origin story resonates with consumers and provides credibility in a market filled with marketing-driven products.
FOUNDING TEAM
Dr. Jatin Joshi - CMO
Associate Professor at UCL, former surgeon with Oxford degree in Evidence-Based Research.
Scott Perkins - CEO
Finance veteran who built supplement brand in 25,000+ US stores.
Darren Crawford - COO
Scaled health brands to 125,000 subscribers and $100M annual revenue.
Nathaneal Mohr - CMO
Serial entrepreneur who built two supplement companies to $10M and $30M annual revenue.
Kerri Kartel - Operations
Scaled supplement company from pre-revenue to $75M with team growth from 10 to 65 people.
Nicole Murphree - Regulatory
15+ years ensuring compliance with FDA, GMP, and international regulations for supplements.
Our founding team combines medical expertise, business acumen, and operational experience. This diverse skill set enables us to address the scientific, commercial, and logistical challenges of building a revolutionary supplement platform.
FINANCIAL PROJECTIONS
Our financial projections show strong growth from 5,000 subscribers in 2025 to 250,000 by 2029. Revenue is expected to increase from $3.5M to $250M during this period, with ARPU (Average Revenue Per User) growing from $700 to $1000 as we introduce additional services and optimize pricing.
Gross margins are projected to improve from 45% to 65% as we achieve economies of scale and automation efficiencies. Retention rates are expected to strengthen from 60% to 80% as our product evolves and customer experience improves. EBITDA is forecast to reach $88.5M (35% of revenue) by 2029.
GO-TO-MARKET STRATEGY
.png){kind=small}
.png){kind=small}
.png){kind=small}
.png){kind=small}
Our launch and expansion strategy focuses on proving the model in a single market before scaling to additional regions. This approach allows us to refine our messaging, optimize customer acquisition costs, and build operational efficiency before rapid expansion.
MANUFACTURING & SCALING
Hand-Made MVP
Initial launch with proven formulation process and limited production capacity creating market scarcity.
Automation Design
Design process for automated liquid handling machinery from life sciences sector already underway.
Scaled Production
Implementation of automation technology enabling rapid scaling with consistent quality and personalization.
Our manufacturing strategy begins with a hand-made MVP that proves the formulation process while creating natural scarcity in the market. As demand grows, we'll implement automated liquid handling machinery from the life sciences sector to enable rapid scaling without compromising on personalization or quality.
This phased approach allows us to validate the product-market fit before making significant capital investments in manufacturing infrastructure, reducing initial risk while preparing for growth.
INVESTMENT OPPORTUNITY
Use of Funds
-
Develop MVP technology platform
-
Establish manufacturing facilities
-
Key hires in operations and marketing
-
Acquire 5,000 customers for $9M ARR
-
Test & refine marketing message, pricing, distribution
Future Funding
Series A ($5-10M) planned for 2026 to:
-
Accelerate growth into additional markets
-
Invest in automation technology
-
Expand team and capabilities
-
Scale to 30,000 subscribers and $22.5M revenue
We're seeking a $1M Seed Round to launch and derisk our business model. This initial funding will allow us to develop our MVP technology platform, establish manufacturing capabilities, make key hires, and acquire our first 5,000 customers, generating $9M in annual recurring revenue.
This seed investment provides an opportunity to participate in transforming a $55B industry with patented technology and a proven team of industry veterans with successful track records.